Endovascular Preparation for Kidney Tranplantation
EndoPreKiT
1 other identifier
observational
58
1 country
1
Brief Summary
This national study is a feasibility study. It wants to validate all stages of the endovascular preparation of the iliac axis up to the kidney transplant for patients in whom the installation of a tailor-made endoprosthesis was necessary beforehand. These patients are currently at a therapeutic impasse. This strategy of renal transplantation on an iliac artery endoprosthesis could ultimately give them access to the transplant with an improvement in quality of life and survival, for lower costs of care for the hospital and safety. less social than treatment by hemodialysis
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2024
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2024
CompletedFirst Submitted
Initial submission to the registry
June 17, 2024
CompletedFirst Posted
Study publicly available on registry
November 6, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2028
ExpectedNovember 6, 2024
November 1, 2024
Same day
June 17, 2024
November 5, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Evaluate the success of endovascular arterial preparation for grafting Renal.
The success of arterial preparation for renal transplantation will be evaluated by: * Collect safety estimators, absence of serious complications (hemorrhage, acute/subacute ischemia of the lower limb, death, serious post-operative cardiorespiratory event, failure of renal function for non-dialysis patients) Validity at 1 month of an endovascular preparation for renal transplantation by tailor-made arterial stent by the success of the installation, the absence of endoleak and the good anteroposterior positioning of the stent * Effectiveness at 1 month of endovascular preparation for renal transplantation by tailor-made arterial stent by permeability confirmed by Doppler ultrasound
"From enrollment to the end of treatment at 12 months
Study Arms (1)
single group of adult patients with chronic renal failure who are all awaiting a kidney transplant
This study focuses on a single group of adult patients with chronic renal failure who are all awaiting a kidney transplant, whether or not they are treated by extra-renal purification. These patients are contraindicated for transplantation due to their anatomical constraints: major arterial calcifications, iliac dissections, iliac stenoses and They can only receive the kidney transplant after arterial preparation.
Interventions
It concerns all patients with chronic renal failure awaiting a kidney transplant, and presenting a contraindication to the transplant due to their anatomical constraints: major arterial calcifications, iliac dissections, iliac stenoses. They can only receive the kidney transplant after arterial preparation. These patients will be included and will benefit from endovascular preparation for the kidney transplant using a tailor-made arterial stent. Imaging examinations and follow-up clinical data will be analyzed. Reinterventions and causes of death will be analyzed. An information sheet will be given to patients; if the patient refuses the use of their data, it will not be collected. Data collection will be carried out by ARCs or PIs of the centers from medical records. The data will be pseudo-anonymized, entered into a REDCAP database shared between each center.
Eligibility Criteria
This study concerns adult patients with chronic renal failure who are all awaiting a kidney transplant, whether or not they are treated by extra-renal purification. These patients are contraindicated for transplantation due to their anatomical constraints: major arterial calcifications, iliac dissections, iliac stenoses and They can only receive the kidney transplant after arterial preparation.
You may qualify if:
- Patient from 18 to 85 years old (beyond 85 years old, guidance must remain exceptional)
- Patients with chronic renal failure
- Waiting for a kidney transplant
- Who have a vascular contraindication to renal transplantation because of their anatomical constraints.
You may not qualify if:
- All criteria contraindicating kidney transplant other than for arterial anatomical problems: All criteria contraindicating kidney transplant other than for arterial anatomical problems:
- A progressive cancer, which is not cured,
- An uncontrolled infectious disease,
- Severe cardiovascular or respiratory disease making general anesthesia impossible,
- Unstabilized psychiatric disorders or illness,
- Dementia proven to have progressed after specialist advice
- Major obesity, with a body mass index greater than 50 kg/m2
- Patient refusal 2. Patient under curatorship 3. Pregnant woman 4. Patients for whom it will not be possible to organize regular medical follow-up
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
HCL Hopital Louis Pradel
Bron, 69500, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 17, 2024
First Posted
November 6, 2024
Study Start
January 1, 2024
Primary Completion
January 1, 2024
Study Completion (Estimated)
January 1, 2028
Last Updated
November 6, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share